118 related articles for article (PubMed ID: 10348370)
21. Schistosoma mansoni: characterization of two protective monoclonal antibodies.
Bickle QD; Andrews BJ; Taylor MG
Parasite Immunol; 1986 Jan; 8(1):95-107. PubMed ID: 3083390
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of mice with a 30 kDa Schistosoma antigen with and without human adjuvant induces high protection against S. mansoni infection.
Attallah AM; Abdel Aziz MM; Abbas AT; Elbakry KA; El-Sharabasy MM
J Helminthol; 2004 Sep; 78(3):189-94. PubMed ID: 15469619
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant selection for vaccination against murine schistosomiasis.
El Ridi R; Tallima H
Scand J Immunol; 2012 Dec; 76(6):552-8. PubMed ID: 22882457
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of recombinant protein r140, a polypeptide segment of tegumental glycoprotein Sm25, as a defined antigen vaccine against Schistosoma mansoni.
Suri PK; Goldberg M; Madikizela M; Petzke MM; Bungiro RD; Davies SJ; Chakraborty B; Nguyen KB; McCray JW; Knopf PM
Parasite Immunol; 1997 Nov; 19(11):515-29. PubMed ID: 9427998
[TBL] [Abstract][Full Text] [Related]
25. Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen.
Soisson LM; Masterson CP; Tom TD; McNally MT; Lowell GH; Strand M
J Immunol; 1992 Dec; 149(11):3612-20. PubMed ID: 1431131
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.
Bungiro RD; Goldberg M; Suri PK; Knopf PM
Infect Immun; 1999 May; 67(5):2340-8. PubMed ID: 10225893
[TBL] [Abstract][Full Text] [Related]
27. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
James SL; Pearce EJ; Sher A
J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
[TBL] [Abstract][Full Text] [Related]
28. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens.
Gregoire RJ; Shi MH; Rekosh DM; Loverde PT
J Immunol; 1987 Dec; 139(11):3792-801. PubMed ID: 2445819
[TBL] [Abstract][Full Text] [Related]
29. Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni.
Richter D; Incani RN; Harn DA
Infect Immun; 1993 Jul; 61(7):3003-11. PubMed ID: 8514407
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the protective immune response induced in mice by immunization with Schistosoma mansoni schistosomula tegument (Smteg) in association with CpG-ODN.
Teixeira de Melo T; Araujo JM; Campos de Sena I; Carvalho Alves C; Araujo N; Toscano Fonseca C
Microbes Infect; 2013 Jan; 15(1):28-36. PubMed ID: 23099420
[TBL] [Abstract][Full Text] [Related]
32. The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice.
Jwo J; LoVerde PT
J Parasitol; 1989 Apr; 75(2):252-60. PubMed ID: 2466975
[TBL] [Abstract][Full Text] [Related]
33. Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential.
Rao KV; He YX; Kalyanasundaram R
Clin Diagn Lab Immunol; 2003 Jul; 10(4):536-41. PubMed ID: 12853382
[TBL] [Abstract][Full Text] [Related]
34. Attempts to induce resistance in mice to Schistosoma japonicum and Schistosoma mansoni by exposure to crude schistosome antigens plus cloned glutathione-S-transferases.
Mitchell GF; Davern KM; Wood SM; Wright MD; Argyropoulos VP; McLeod KS; Tiu WU; Garcia EG
Immunol Cell Biol; 1990 Dec; 68 ( Pt 6)():377-85. PubMed ID: 2129038
[TBL] [Abstract][Full Text] [Related]
35. Prospects for a nonliving vaccine against schistosomiasis based on cell-mediated immune resistance mechanisms.
James SL; Pearce EJ; Sher A
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():121-3. PubMed ID: 3151085
[TBL] [Abstract][Full Text] [Related]
36. Characterization and cloning of Schistosoma mansoni immunogens recognized by protective antibodies.
Strand M; Dalton JP; Tom TD
Acta Trop Suppl; 1987 Jun; 12():75-82. PubMed ID: 2442989
[TBL] [Abstract][Full Text] [Related]
37. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
Pacífico LG; Fonseca CT; Chiari L; Oliveira SC
Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
[TBL] [Abstract][Full Text] [Related]
38. Schistosoma mansoni polypeptides immunogenic in mice vaccinated with radiation-attenuated cercariae.
Dalton JP; Strand M
J Immunol; 1987 Oct; 139(7):2474-81. PubMed ID: 3116082
[TBL] [Abstract][Full Text] [Related]
39. Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. VI. Antigen recognition by non-responder mouse strains.
James SL; Salzman C; Pearce EJ
Parasite Immunol; 1988 Jan; 10(1):71-83. PubMed ID: 3127798
[TBL] [Abstract][Full Text] [Related]
40. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
